Eli Lilly and Company
Eli Lilly and Company, commonly referred to as Lilly, is a prominent pharmaceutical preparation manufacturer headquartered in the United Kingdom. With a strong presence across major global markets, the company specialises in developing innovative medicines for a range of therapeutic areas, including diabetes, oncology, and neuroscience. Founded in 1876, Lilly has a long-standing history of advancing healthcare through groundbreaking research and development.
The company’s core products include biologics, small-molecule drugs, and specialised therapies that distinguish it within the pharmaceutical industry. Recognised for its commitment to scientific excellence and patient-centred solutions, Eli Lilly has achieved notable milestones in drug innovation and market leadership. Its strategic focus on cutting-edge pharmaceuticals positions Lilly as a key player in the global healthcare landscape.
+14 vs industry average
Eli Lilly and Company’s score of 54 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Eli Lilly and Company?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has typical carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Eli Lilly and Company's reported carbon emissions
Eli Lilly and Company, a pharmaceutical preparation manufacturer headquartered in Great Britain, reported a total of 708,000,000 kg CO2e in Scope 1 and Scope 2 emissions for 2024. This includes approximately 192,000,000 kg CO2e in Scope 1 emissions and approximately 258,000,000 kg CO2e in Scope 2 emissions (market-based). For 2023, the company's combined Scope 1 and 2 emissions were approximately 527,000,000 kg CO2e, with Scope 3 emissions totalling approximately 5,139,500,000 kg CO2e.
Eli Lilly has set several emissions reduction targets. The company achieved a 26% absolute emissions reduction in its own operations (Scope 1 and 2) between 2020 and 2023. Additionally, Eli Lilly is committed to achieving carbon neutrality in its own operations (Scope 1 and 2 emissions) by 2030. The company also previously aimed for a 20% reduction in facility energy greenhouse gas emissions (Scope 1 and location-based Scope 2) per square foot by the end of 2020, using 2012 as a base year, and reported being 80% towards this goal in 2019.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Eli Lilly and Company’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
10 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project